# A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy

> **NCT01487070** · PHASE1 · COMPLETED · sponsor: **Retina Institute of Hawaii** · enrollment: 5 (actual)

## Conditions studied

- PDR

## Interventions

- **DRUG:** Macugen (Pegaptanib Sodium)

## Key facts

- **NCT ID:** NCT01487070
- **Lead sponsor:** Retina Institute of Hawaii
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2011-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01487070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01487070, "A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01487070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*